Researchers should no longer delay implementation of Pap screening in low and middle income countries pending...

Area of Science:

• Gynecology
• Public Health
• Oncology

Background:

• Novel cervical cancer screening and triage methods for low and middle-income countries (LMICs) are being explored.
• Current novel approaches often rely on HPV screening tests that are not affordable in LMICs and triage tests unavailable at the point of care.
• Historically, research into less suitable screening methods has delayed the implementation of effective Pap smear screening in LMICs, leading to preventable deaths.

Discussion:

• Pap smears are a feasible, affordable, and well-suited option for single-visit, point-of-care cervical screening and triage in LMICs.
• The study highlights the critical need to avoid delays in implementing effective screening methods.
• Prioritizing immediate life-saving interventions is crucial in LMICs.

Key Insights:

• Pap smear screening is a viable and immediate solution for cervical cancer prevention in LMICs.
• Delays in adopting proven screening methods like Pap smears have severe public health consequences.
• Focus should shift to rapid implementation of accessible screening technologies.

Outlook:

• Implement high-quality, single-visit, point-of-care Pap smear screening in LMICs without delay.
• Continue research and development to make advanced HPV screening more affordable and accessible for LMICs.
• The ultimate goal is to reduce cervical cancer mortality globally through accessible and effective screening programs.